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Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is caused by multiple factors including hepatic oxidative stress,
lipotoxicity, and mitochondrial dysfunction. Obesity is among the risk factors for NAFLD alongside type 2 diabetes
mellitus and hyperlipidemia. α- mangostin (α-MG) extracts from the pericarps of mangosteen (Garcinia mangostana
Linn.) may regulate high fat diet-induced hepatic steatosis; however the underlying mechanisms remain unknown.
The aim of this study was to investigate the regulatory effect of α-MG on high fat diet-induced hepatic steatosis and
the underlying mechanisms related to mitochondrial functionality and apoptosis in vivo and in vitro.
Methods: Sprague Dawley (SD) rats were fed on either AIM 93-M control diet, a high-fat diet (HFD), or high-fat diet
supplemented with 25 mg/day mangosteen pericarp extract (MGE) for 11 weeks. Thereafter, the following were
determined: body weight change, plasma free fatty acids, liver triglyceride content, antioxidant enzymes (superoxide
dismutase, SOD; glutathione, GSH; glutathione peroxidase, GPx; glutathione reductase GRd; catalase, CAT) and
mitochondrial complex enzyme activities. In the in vitro study, primary liver cells were treated with 1 mM
free fatty acid (FFA) (palmitate: oleate acid = 2:0.25) to induce steatosis. Thereafter, the effects of α-MG (10 μM, 20 μM,
30 μM) on total and mitochondria ROS (tROS, mitoROS), mitochondria bioenergetic functions, and mitochondrial
pathway of apoptosis were examined in the FFA-treated primary liver cells.
Results: The MGE group showed significantly decreased plasma free fatty acids and hepatic triglycerides (TG) and
thiorbarbituric acid reactive substances (TBARS) levels; increased activities of antioxidant enzymes (SOD, GSH, GPx, GRd,
CAT); and enhanced NADH-cytochrome c reductase (NCCR) and succinate-cytochrome c reductase (SCCR) activities in
the liver tissue compared with HFD group. In the in vitro study, α-MG significantly increased mitochondrial membrane
potential, enhanced cellular oxygen consumption rate (OCR), decreased tROS (total ROS) and mitoROS (mitochondrial
ROS) levels ; reduced Ca2+ and cytochrome c (cyt c) release from mitochondria, and reduced caspases 9 and 3 activities
compared with control group.
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Conclusion: These findings demonstrate α-MG attenuated hepatic steatosis in high fat-diet fed rats potentially through
enhanced cellular antioxidant capacity and improved mitochondrial functions as well as suppressed apoptosis of
hepatocytes. The findings of study represent a novel nutritional approach on the use of α-MG in the prevention and
management of NAFLD.
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Background
Non-alcoholic fatty liver disease (NAFLD) is among the
most common chronic liver diseases and its prevalence is
associated with the increase in obesity and other meta-
bolic syndrome conditions [1, 2] The hallmark of NAFLD
is hepatic steatosis, which manifests as excessive triglycer-
ide accumulation in the hepatocytes [2]. The pathogenesis
of NAFLD is generally described by ‘two-hit’ theory repre-
sented by initial step of hepatic lipid accumulation and
thereafter hepatic cellular injury due to lipotoxicity medi-
ated by lipid peroxidation and pro-inflammatory factors
[1]. Hepatic steatosis mainly results from disrupted lipid
metabolism in the hepatocytes leading to imbalance
between intrahepatic triglyceride (TG) accumulation and
clearance [3]. Among the underlying reasons for the fat
accumulation is the failure of long chain fatty acids catab-
olism due to impaired hepatic mitochondrial β-oxidation
[1]. The increased FFA flux in the hepatocytes increase
the production of free radicals and other reactive oxygen
species (ROS) leading to intracellular redox imbalance.
Due to the reactive nature of the ROS, the antioxidant
enzyme activities are suppressed resulting in oxidative
stress and hepatic cellular injury [4].
Hepatic lipid accumulation in NAFLD setting has been
associated with mitochondrial dysfunction arising mainly
from cellular oxidative damage [1]. Mitochondria are
key sources of ROS in the cell mainly due to mitochon-
drial uncoupling disturbances and inhibition of the
respiratory chain leading to free radical leakage in the
electron transport chain [5]. A previous study found rat
fed on high fat diet had increased levels of free fatty acid,
oxidative stress, and decreased antioxidant enzymes
activity, which collectively induced mitochondrial proton
leakage [6]. The imbalance between the mitochondria
antioxidant capacity and generated ROS affects the
mitochondria integrity and catabolic functions such as
β-oxidation of fatty acids thereby resulting in excessive
hepatic triglyceride accumulation [4].
Apoptosis of hepatocytes is a critical feature of
NAFLD and is associated with structural changes in the
liver tissues leading to physiological and pathological con-
ditions [7]. The role of mitochondria-dependent apoptosis
in the development of hepatic steatosis has been hypothe-
sized by several authors [8]. Oxidative stress can interfere
with mitochondria membrane integrity including loss of
mitochondrial membrane potential (Δψm), release of Ca2+,
activation of caspases 9 and 3; reduction of Bcl-2/Bax ratio
and release of cytochrome c leading to programmed
hepatocytes cell death [9]. The main consequence of hep-
atocyte apoptosis is dysregulated lipid clearance resulting in
triglyceride accumulation. On the other hand, oxidative
stress can also cause hepatocytes apoptosis through the
redox signalling [8].
In recent years, several studies have explored the modi-
fication of the risk factors such as oxidative stress as
potential therapeutic targets for NAFLD through the use
of antioxidants and dietary bioactive compounds [1, 4].
Mangosteen (Garcinia mangostana Linn.) is a tropical
fruit that contains a wide range of bioactive compounds
such as xanthones, anthocyanins, tannins and the benefi-
cial health effects have been linked to the anti-oxidative,
anti-bacterial, anti-cancer and anti-adipogenic effects
[4, 10]. α- mangostin (α-MG) is the main constituent
of the fruit hull of the mangosteen, and possesses a
wide variety of pharmacological effects including in-
hibition of inflammation; inhibition of ROS through
enhanced anti-oxidative enzymes activities [11]; and
improvement of metabolic disorders of high fat-diet fed
mice [4]. Previous studies showed α-MG significantly
reduced lipid peroxidation and improved antioxidant cap-
acity in fat-infiltrated liver [4, 12]. Choi et al. found α-MG
treatment could alleviate obesity in a mice model through
induction of adenosine 5’-monophosphate (AMP)-acti-
vated protein kinase (AMPK) protein [12]. Nevertheless,
the effect of mangosteen on hepatic lipid homeostasis in
NAFLD setting has not been elucidated and the under-
lying mechanisms related to mitochondria functionality
and apoptosis remain unknown. Thus, our study aimed at
investigating the regulatory effects of mangosteen pericarp
extract on hepatic fat- accumulation in high-fat diet fed
rats, and further examine the underlying mechanisms
related to mitochondrial functionality and apoptosis in
vivo and in vitro.
Methods
Reagents
Palmitic acid, oleic acid, pure α-MG (>99%), 1% Penicil-
lin/Streptomycin (PS), and dimethyl sulfoxide (DMSO)
were obtained from Sigma-Aldrich (US). Leibovitz’s L-15
medium was purchased from ThermoFisher, (US),
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whereas fetal bovine serum (FBS) was obtained from
GIBCO Co. (US). Mangosteen pericarp extract was ob-
tained from Shinn Nan World Trade Co., Ltd. (Taipei,
Taiwan) and contained 84% total mangosteen xanthones
as α-mangostin.
Animal experiment
The animal experiment protocol was reviewed and
approved by the Institutional Animal Care and Use com-
mittee (IACUC/IACUP) at Taipei Medical University
(IACUC approval No: LAC-2015-0109). Adult male SD
rats (240.2 ± 1.5 g, 6–7 weeks old were obtained from
BioLASCO Taiwan Co., Ltd. (Taiwan) and maintained
under specific-free conditions at 22 °C on a 12 h light–
dark cycle with ad libitum access to food and water.
After 1 week of acclimatization, the rats were equally
divided into three groups (n = 8): (i)AIN 93 M diet (con-
trol) from MP Biomedicals (US) (ii) High fat diet group
(HFD) - AIN93M modified high fat diet (iii) MG group
(MGE) -25 mg/day mangosteen extract with AIN93M
modified high fat diet. The caloric distribution of the
control group was 77%: 9%:14% of energy provided as
carbohydrate: fat: protein, respectively whereas the cal-
oric distribution of the HFD group was 28%: 60%:11%,
of energy provided as carbohydrate: fat: protein, respect-
ively. Lard was used as the major fat source in the diet.
The amount of food consumed by the rats in the
respective groups were not significantly different i.e. con-
trol group - 19.79 ± 0.34 g/per day; HFD group- 19.67 ±
0.54 g/per day; and MGE group- 19.41 ± 1.02 g/per day.
The rats were weighed every week during the experiment
period. After 11 weeks of feeding, the rats were fasted
overnight and sacrificed. The liver tissues were removed,
weighed and thereafter subjected to histology examin-
ation. All samples were stored at −80 °C prior to analysis
of hepatic triglyceride and free fatty acids content, hepatic
oxidative damage expressed as Thiobarbituric acid-
reactive substances (TBARS), antioxidant enzyme activ-
ities, and mitochondrial complex enzyme activities.
Isolation of primary hepatocytes and Free fatty acid
(FFA)-treatment experimental design
Primary hepatocytes were isolated from 6 to 8 weeks old
male SD rats weighing 150–200 g, through portal vein
collagenase perfusion of liver as per the method of
Seglen [13]. Hepatocytes were cultured for 24 h in
Leibovitz’s L-15 medium supplemented with 1 μmol/L
dexamethasone and 2.5% FBS (supplemented with
5.6 mM/L galactose, and 1% penicillin/streptomycin). A
typical yield was about 4–5 × 107 hepatocytes/rats with
>80% cell viability as determined by trypan blue exclu-
sion assay. In order to induce fat infiltration to simulate
hepatic steatosis, rat primary hepatocytes were placed in
6-well plates (2 × 105 cells) and cultured for 24 h in 10%
FBS media supplemented with 1 mM free fatty acid
(FFA) (palmitate: oleate acid =2:1) as previously de-
scribed [14]. The primary hepatocytes were treated with
different α-MG concentrations (10 μM, 20 μM and
30 μM) were dissolved before use DMSO for 24 h. These
dosages fall within the ranges previously studied by
other authors [15]. Analyses were conducted for cellular
oxygen consumption rate (OCR), total and mitochon-
drial ROS, cytochrome c release, caspase-3 and −9, and
mitochondrial membrane potential.
Analysis of hepatic triglyceride and plasma free fatty
acids profile
The plasma free fatty acid concentrations were deter-
mined by enzymatic colorimetric methods using com-
mercial kits (Randox, UK). The lipids were extracted
from liver samples using chloroform–methanol method
[16]. The liver TG levels in the lipid extracts were deter-
mined by enzymatic colorimetric methods using com-
mercial kits (Randox, UK).
Hepatic histology
Liver tissues were fixed overnight at room temperature
in 10% formaldehyde and embedded in paraffin. Thick
sections (8 μm) were stained with hematoxylin & eosin
and mounted on glass slides and examined using a
microscope (Leica ICC50 HD, Germany) (original mag-
nification × 200).
Hepatic TBARS assay
As a marker of oxidative damage from lipid peroxida-
tion, the TBARS concentrations were measured in the
liver tissue and primary hepatocytes using the method of
Park et al. [17]. First, the supernatant (20 μL) was mixed
with 0.22% H2SO4 (800 μL), phosphotungstic acid (PTA)
(100 μL) and thiobarbituric acid (TBA) (200 μL). The re-
action mixture was heated at 95 °C for 1 h, and cooled
for 10 min. Thereafter butanol (400 μL) was added to
the mixture and vortexed. The mixture was centrifuged
at 25 °C for 15 min (650 × g) and the supernatant fluor-
escence measured using TBARS Assay Kit (Cayman, US)
at excitation and emission wavelengths of 530 nm and
590 nm, respectively.
Assay of hepatic antioxidant enzymes activities
Liver tissue (0.5 g) was homogenized in 1.5 mL buffer
(20 M Tris-base,7 VM NaCl, 1% Triton X-100, pH 7.2,
0.1% protease inhibitor) and incubated at 4 °C, vortexing
every 10 min up to 90 min. The homogenate was centri-
fuged at 4 °C, for 15 min (3000 × g). The supernatants
were collected and stored at −30 °C for further analysis.
The amount of protein in supernatant was measured
using bicinchoninic acid (BCA) kit (ThermoFisher, US).
Superoxide dismutase (SOD) activity was analyzed using
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commercial kit (ENZO, UK). The glutathione (GSH) and
catalase (CAT) activities were measured using respective
commercial kits (Cayman, US). The glutathione reduc-
tase (GRd) and glutathione peroxidase (GPx) activities
were determined using respective commercial kits
(Randox, UK).
Analysis of hepatic mitochondrial complex enzyme
activity
In the determination of nicotinamide adenine dinucleotide-
cytochrome c reductase (NCCR) activity, 900 μL test solu-
tion (1 mM NADH, 1.5 mM potassium cyanide, 50 mM
potassium phosphate buffer, pH 7.4) was added to 200 μg
of liver mitochondrion extract and incubated at 37 °C for
3 min. Thereafter, 1 mM oxidized cytochrome c (100 μL)
was added. The activity absorbance was measured spectro-
photometrically at 550 nm for 3 min. In the succinate-
cytochrome c reductase (SCCR) activity assay, 900 μL test
solution (22 mM succinate, 1.66 mM potassium cyanide,
44 mM potassium phosphate buffer, pH 7.4), was mixed
with liver mitochondrion extract (200 μg) and 0.5 mM
oxidized cytochrome c (100 μL), and incubated at 37 °C for
2 min. The SCCR activity was measured spectrophotomet-
rically at 550 nm for 3 min.
Determination of cellular oxygen consumption rate (OCR)
The FFA-treated rat primary hepatocyte (5 × 104 cells
per well) were cultured in plates for the analysis of the
cellular oxygen consumption rate using XFe24 Analyzer
plates (Seahorse Bioscience, US). The analyzer was
sequentially injected with the three mitochondrial in-
hibitor compounds (oligomycin, carbonylcyanide p-tri-
fluoromethoxyphenylhydrazone, CCCP; and antimycin
A) through the assigned ports. The OCR was
expressed as pMole/min.
Total ROS (tROS) and mitochondrial ROS (mitoROS) assay
tROS was determined in the FFA-treated primary hepa-
tocytes by analysis of 2,7-dichlorodihydrofluorescein
diacetate (H2DCFDA) using a commercial kit (Cayman,
US). mitoROS was examined using MitoSOX™ Red com-
mercial kit (Cayman, US)..
Assay of mitochondrial membrane potential, cytochrome
c (cyt c), and caspase (3 and 9) activities
Mitochondrial membrane potential was determined using
MitoProbe™ JC-1 assay kit. (ThermoFisher, US). Cyt c
assay was evaluated using cyt c releasing apoptosis assay
kit (Biovision, US). The cyt c release was determined by
western blotting of the cell homogenate of the cytosolic
and mitochondrial fractions. Caspases-3 and 9 assays were
evaluated using caspase-3/CPP32 and 9 colorimetric assay
kits, respectively (Biovision, US). The cells were sonicated
to obtain protein concentration of 100 μg/mL. After
addition of reaction buffer and DTT to the protein extract,
DEVD-pNA (caspase 3) or LEHD-pNA (caspase 9) sub-
strate were added to the mixture and incubated at 37 °C
for 2 h. The samples absorbance were read at 405 nm
using a spectrophotometer.
Statistical analysis
Data are expressed as the mean ± standard deviation.
The differences between the mean values were evalu-
ated by ANOVA followed by Duncan’s multiple range
test. In all analyses, p-values < 0.05 were considered
statistically significant.
Results
Mangosteen pericarps extract markedly reduced body
weight gain, plasma free fatty acids (FFA) levels, hepatic
triglyceride (TG) accumulation
Mangosteen pericarps extract supplementation signifi-
cantly decreased body weight in the MGE group com-
pared to HFD group (Fig. 1a). After feeding the SD rats on
high fat diet (HFD) for 11 weeks, plasma FFA (Fig. 1b)
and hepatic TG concentration (Fig. 1d) were markedly
increased in HFD group thereby confirming the primary
goal of inducing fat accumulation in the animal model
was successful. This is further supported by the hepatic
histology images that showed increased lipid deposition in
the hepatocytes of the HFD group showed compared to
control and MGE groups (Fig. 1c). Mangosteen pericarps
extract supplementation significantly reduced hepatic TG
concentration (Fig. 1d) and plasma FFA levels (Fig. 1b)
MGE group compared to HFD group. Mangosteen peri-
carps extract also significantly reduced TBARS levels, a
marker of lipid peroxidation, in the MGE group (Fig. 1e).
Mangosteen pericarps extract increased hepatic
antioxidant enzyme activities and reduced ROS in rat liver
tissue
Mangosteen pericarps extract treatments increased anti-
oxidant enzymes (SOD, GSH, GPx, GRd, CAT) activities
in the rat liver tissue in MGE group compared to HFD
group (Table 1). These results demonstrate mangosteen
extract could confer a protective effect by enhancing
hepatic antioxidant enzymes activities. In the in vitro
study, α-MG treatment decreased TBARS concentration
in FFA-treated hepatocytes (Fig. 2a) and decreased tROS
(Fig. 2b) and mitoROS (Fig. 2c) concentration in FFA
-treated hepatocytes. Overall, our study found α-MG
decreased oxidative stress in FFA -treated hepatocytes.
α-MG suppressed mitochondrial pathway of apoptosis in
FFA-treated hepatocytes
α-MG treatments (10 μM, 20 μM and 30 μM) decreased
Ca2+ (Fig. 2e) and cytochrome c levels (Fig. 2d), de-
creased caspases 9 and 3 activities (Fig.3a), and
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decreased mitochondrial membrane potential (Fig. 3b)
in FFA-treated primary hepatocytes. Our results implied
α-MG suppressed the early phase of mitochondrial-
dependent apoptosis.
α-MG treatment enhanced mitochondrial function and
enzyme activities
α-MG treatment increased NCCR (mitochondrial com-
plex I and III) and SCCR (mitochondrial complex II and
III) activities in MGE group compared to HFD group
(Fig. 3c). Our results showed significantly increased
mitochondrial oxygen consumption rate in the 20 μM
α-MG treatment compared to control in FFA-treated
hepatocytes (Fig. 3d). These data show α-MG of mango-
steen pericarps extract treatment could improve effi-
ciency of mitochondrial functions such as oxidative
phosphorylation and enzyme activities.
Discussion
We evaluated the regulatory effects of mangosteen peri-
carp extract on hepatic fat-accumulation in high-fat diet
fed rats, and further examine the underlying mecha-
nisms related to mitochondrial functionality and apop-
tosis in vivo and in vitro. In this study, the weight
change in the MGE group was markedly lower than in
the HFD-control diet (Fig. 1a), and MGE further sup-
pressed accumulation of free fatty acids (Fig. 1b), lipid
deposition in hepatocytes (Fig. 1c) and triglyceride
(Fig. 1d) compared to the levels in the HFD group. We
report here for the first time, that the MGE suppressed
effect on hepatic triglyceride accumulation could be
directly or indirectly attributed to modulation of the
antioxidant capacity, mitochondrial bioenergetic func-
tionality and mitochondria-dependent apoptosis. Our
findings on suppressed triglyceride were in agreement
with a previous study that showed improved biochemical
serum profiles (total cholesterol, triglyceride, and fatty
acid) in high fat diet fed mice after supplementation with
α-MG (50 mg/kg) for 80 days [4]. Choi et al. also re-
ported anti-obesity effects of α-MG in HFD induced
Table 1 Effect of mangosteen peel extract on hepatic antioxidant
enzyme activity in high fat diet-fed rats
Control HFD MGE
GSH (mole/mg protein) 96.9 ± 2.2 93.0 ± 0.7* 96.5 ± 1.6#
GPx (U/mg protein) 0.98 ± 0.08 0.85 ± 0.14* 0.95 ± 0.08#
GRd (U/g protein) 0.82 ± 0.2 0.66 ± 0.14* 0.96 ± 0.21#
SOD (Unit/min/mg protein) 0.02 ± 0.03 0.14 ± 0.05* 0.20 ± 0.03#
CAT (Kunits/mg protein) 19.5 ± 2.8 14.3 ± 5.3* 19.9 ± 2.6#
Values are mean ± SD (n = 8); means without a common letter differ (p < 0.05).
GSH: glutathione; GPx: glutathione peroxidase; GRd: glutathione reductase;
SOD: superoxide dismutase; CAT: catalase. HFD: high fat diet; MGE: HFD
supplemented 25 mg/day mangosteen extract diet (*P < 0.05 versus
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Fig 1 Effect of mangosteen pericarp extracts on: a body weight change, b FFA in plasma, c representative images of hematoxylin and eosin
stained liver tissue. Original magnification, ×200, d Liver TG concentration, e Liver TBARS concentration. FFA: free fatty acid, TG: triacylglycerol,
TBARS: thiobarbituric acid reactive substances. c: control; HFD: high fat diet; MGE: HFD supplemented with 25 mg/day mangosteen pericarp
extract. Values are mean ± SD (n = 8); (*P < 0.05 versus control ; #P < 0.05 versus HFD)
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obese mice by activating SirT1-AMPK and PPARγ path-
ways [12]. Overall, these data including in our study sug-
gest that α-MG could potentially regulate hepatic
steatosis in an obesity setting.
ROS are critical factors in the pathogenesis of NAFLD
leading to cellular damage and mitochondrial dysfunc-
tion. As evident in our study, MGE enhanced the cellu-
lar antioxidant enzyme activities including GPx, GRd,
SOD, CAT, and GSH (Table 1), which could explain the
substantial decline in tROS (Fig. 2b), and mitoROS
(Fig. 2c) in the MGE treatment. The reduced ROS levels
implied increased cellular protection as supported by
decline in TBARS (Fig. 2a), a potential indicator of oxi-
dative cellular damage due to lipid peroxidation. Mango-
steen pericarps are rich sources of xanthones bioactive
compounds that could have enhanced the endogenous
antioxidant defence. Diminished GSH has previously
been implicated in the pathogenesis of alcohol liver dis-
eases [18]. In a previous study, Marquez-Valadez et al.
found α-MG (10 μM, 25 μM and 50 μM) significantly
increased GPx activity in rat brain synaptosomes with 3-
NP-induced mitochondrial dysfunction [19]. Fang et al.
studied ARPE-19 cells with H2O2-induced high cellular
stress and found α-MG treatment (200 μM) decreased
TBARS levels and increased SOD, GPx and GSH activ-
ities [20]. Shen et al. reported effects of α-mangosteen in
the regulation of antioxidant sensor NRF2 transcription
factor on regulation of transcription and redox status in
adipocyte [21]. The authors attributed these observations
to α-MG regulation of mitogen-activated protein kinases
(MAPKs), extracellular signal-regulated kinase (ERK)1/2,
JNK and p38 protein expression [20].
Emerging evidence has shown defects in mitochondrial
bioenergetics may have a role in the development of
liver diseases especially in an obesity setting [18]. Mito-
chondrial dysfunction can lead to an imbalanced trigly-
ceride accumulation via reduced mitochondrial fatty
acids oxidation mechanism. Therefore, reduced ROS
and suppressed TBARS in the αMG treatment suggested
mitochondrial protection from oxidative damage. In our
FFA (1mM) - - + + + +





















































































































- - + + + + FFA























FFA (mM) - - 1 1 1 1
α-MG(uM) - 10 10 20 30
Fig 2 α-MG treatment decreased a TBARS, b tROS, c mitoROS, d cyt c, e Ca2+ in FFA-treated primary hepatocyte. The primary liver cells were
treated with α-MG (10, 20, 30 μM) for 24 h. Thiobarbituric acid reactive substances (TBARS), tROS and mitoROS were quantified by flow cytometry,
whereas Ca2+ concentration were quantified by colorimetry assays. Cyt c level was quantified by western blotting. Values are means ± SD, n = 3.
(*P < 0.05 versus primary liver cells ; #P < 0.05 versus FFA-induced hepatocyte)
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study, αMG treatment showed enhanced OCR (Fig. 3d),
NCCR (mitochondrial complex I and III) and SCCR
(mitochondrial complex II and III) (Fig. 3c), which are
critical aspects of cell bioenergetics and mitochondrial
oxidative phosphorylation relating to breakdown triglyc-
erides for energy metabolism. In our study, improved
mitochondrial oxidative phosphorylation is also evident
from the enhanced mitochondrial membrane potential
in the αMG treatment (Fig. 3b).
On the other hand, loss of mitochondrial membrane
potential is strongly associated with apoptosis signalling
via release of Ca2+, cytochrome c and caspases. As
shown in our study, control group showed markedly
reduced mitochondrial membrane (Fig. 3b), which corre-
sponded to enhanced release of Ca2+ (Fig. 2e), cyto-
chrome c (Fig. 2d), and caspase activity (Fig. 3a)
compared to αMG group. Our findings are comparable
to those of Moravcova et al., who found 1 mM fatty acid
mix (palmitate: oleate acid, 2:1) treatment increased
triglyceride, ROS, caspase 3 and reduced mitochondrial
membrane potential (Δψm) in primary liver cells, and
further recommended in vitro models as suitable tools
for studying hepatocellular consequences of steatosis
[22]. Increased apoptosis of hepatocytes can lead to
rapid cell death and inability of the cells to effectively
modulate the lipid metabolism leading to hyperlipid-
emia. In our study, incorporation of αMG improved
mitochondrial membrane potential and suppressed levels
of Ca2+, cytochrome c, and caspase activity. Thus, the
reduced triglyceride accumulation could partly be attrib-
uted to suppressed hepatocellular apoptosis via im-
proved mitochondrial membrane potential and overall
improved cell functions.
The alternative explanation for the reduced apoptosis
levels in the MGE group can be due to the improved
cellular antioxidant capacity as evident in the reduced
tROS, increased antioxidant enzyme activities (Table 1),
and reduced oxidative damage due to lipid peroxidation
(Fig. 2a). ROS plays an important role in mediating apop-
tosis via redox signaling of ASKI signalosome/JNK path-
ways [9]. In an earlier study, Janhom and Dharmasaroja,
suggested the inhibition effect of α-MG against MPP+-in-
duced apoptosis in neuroblastoma SH-SY5Y cells may be
associated with the reduction of ROS production, modula-
tion of the balance of pro- and anti-apoptotic genes, and
suppression of caspase-3 activation [23]. Kwak et al., in a
recent study indicated α-MG treatment suppressed cell





























































































































Fig 3 Effect of α-MG treatment on : a caspases 9 and 3 activities, b mitochondria membrane expressed as JC-1 fluorescence, d OXPHOS expressed
as oxygen consumption rate in FFA-treated hepatocytes. The primary liver cells were treated with α-MG (10, 20, 30 μM) for 24 h. OXPHOS was quantified
by seahorse XFe24 Analyzer. Caspases 9 and caspases 3 were quantified by Elisa assays. (*P< 0.05 versus primary liver cells ; #P< 0.05 versus FFA-treated
hepatocytes). Values are means ± SD, n= 3. Effect of mangosteen pericarp extract on mitochondrion complex enzymes (NCCR, SCCR) c. OXPHOS: oxidative
phosphorylation. NCCR: NADH-cytochrome c reductase. SCCR: succinate-cytochrome c reductase. Values are mean ± SD (n = 8); (*P < 0.05
versus control; #P < 0.05 versus HFD)
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related proteins (CDK/cyclin) in human oral squamous cell
carcinoma [24]. Shan et al. reported α-MG (7 μg/mL)
treatment markedly suppressed human gastric adeno-
carcinoma cells via the constitutive Stat3 protein acti-
vation, and Stat3-regulated Bcl-xL and Mcl-1 protein
levels [25]. The question that remains in the current
study is the potential molecular targets for the α-MG
modulation of hepatic triglyceride accumulation and
apoptosis, hence future studies are warranted to eluci-
date the molecular mechanisms by which α-MG mod-
ulates hepatic lipid homeostasis via mitochondrial
functionality and apoptosis pathways.
Overall, Fig. 4 describes our proposed model for the
α-MG regulatory effect on hepatic steatosis in high
fat diet fed rats. High fat diet led to overload of FFA/
triglycerides, increased lipid peroxidation and ROS
production in the liver, further suppressing the anti-
oxidant capacity and causing mitochondrial damage.
Mitochondrial damage led to increased cytochrome c
and Ca2+ release from mitochondria, and subsequent
activation of caspases 9 and 3, eventually leading to
hepatocyte apoptosis via mitochondria-dependent
pathways. The mitochondrial damage in turn leads to
a decrease in mitochondrial oxidative capacity, includ-
ing β-oxidation and ATP production, and conse-
quently excessive triglyceride accumulation in the
liver. Upon supplementation of high fat diet with
α-MG from mangosteen pericarps, the antioxidant en-
zymes activities were enhanced, leading to decreased
ROS levels and increased hepatic mitochondrial oxi-
dative phosphorylation capacity and efficient catabol-
ism of accumulated hepatic triglyceride. On the other
hand, α-MG resulted in decreased hepatocyte apop-
tosis via improved mitochondrial integrity and dimin-
ished oxidative stress. This means that the liver cells
role in lipid metabolism were not dysregulated by the
programmed cell death arising from mitochondria-
dependent apoptosis. Chitchumroonchokcha et al.
studied the bioavailability of xanthones in human sub-
jects and observed all the participants completed the
study with no gastrointestinal distress after consuming
the test sample of 60 mL mangosteen juice (59%
α-mangostin) [26]. The findings of this human study
are a good indication on the safety of the α-MG
extract and the potential application of the α-MG in
therapeutic management of NAFLD.
Fig. 4 Proposed mechanism for α-MG action against fat infiltration of the liver. High fat diet in an obesity setting, leads to overload of
FFAs in hepatocytes. Consequently, there occurs increased ROS production and lipid peroxidation in the liver, which further damage the
antioxidant enzymes and mitochondria. Mitochondrial damage leads to cyt c and Ca2+ release from mitochondria, thereafter cyt c binds
to Apaf-1 and activates apoptosis via caspases 9 and 3 factors. Apoptosis implies rapid death of hepatocytes hence reduced clearance of fat deposits.
On the other hand, mitochondrial damage in turn leads to a decreased mitochondrial oxidative capacity, including β-oxidation and ATP production,
resulting in TG accumulation in the liver. α-MG limits hepatic TG accumulation through enhanced anti-oxidative capacity and hepatic mitochondrial
oxidative metabolic capacity and inhibition of mitochondrial pathway of apoptosis, which may confer decreased hepatic steatosis risk. ROS: reactive
oxygen species; Ca2+ : calcium ; cyt c : cytochrome c ; TG: triglyceride
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Conclusion
Our study demonstrates that α-MG suppressed hepatic
steatosis in high fat diet- fed rats via various mechanisms
including increased antioxidant enzyme capacity,
improved mitochondrial functionality and suppressed
mitochondria-dependent apoptosis. These data indicate
α-MG extracts from mangosteen pericarps may be used
as a preventive agent for hepatosteatosis through regu-
lating mitochondrial oxidative phosphorylation and
apoptosis mechanisms.
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